University of Vermont Cancer Center Member Profile
Steven Ades, MD
Professor, Medicine-Hematology Oncology
Director, Clinical Trial Office
Full Member
Academic Interests
Dr. Ades' research focuses on how to best identify patients who are at the highest risk of developing deep venous clots or pulmonary embolism in the setting of cancer and how to prevent these complications from occurring.
Postdoctoral Training
2002-2005..... Masters Degree in Epidemiology and Biostatistics
2000-2002..... Research Fellow, Tufts University School of Medicine, Boston, MA
1999-2002..... Hematology/Oncology Fellowship, Tufts University, Boston MA
1996-1999..... Queens University postgraduate education in Internal Medicine (Kingston General & Hotel Dieu Hospitals, Kingston, Ontario)
Education
1992-1996..... McGill University, Montreal, Canada; MDCM
1989-1992..... McGill University, Montreal Canada; BS
Publications
To view more and/or the most recent publications by Steven Ades please visit their biblography here.
Ng HK, Rogala BG, Ades S, Schwartz JR, Ashikaga T, Vacek P, Holmes CE. Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation. J Oncol Pharm Pract. 2020 Feb 11: 1078155220901569. doi: 10.1177/1078155220901569. PMID: 32046579
Douce DR, Holmes CE, Cushman M, MacLean C, Ades S, Zakai NA. Risk Factors for Cancer-Associated Venous Thromboembolism: the Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PAAC) Study. J Thromb Haemost. 2019 Aug 18. doi: 10.1111/jth.14614. PMID: 31423717
Yang MX, Coates RF, Ambaye A, Cortright V, Mitchell JM, Buskey AM, Zubarik R, Liu JG, Ades S, Barry MM. NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors. Biomark Res. 2018 Apr 18,6:15. doi: 10.1186/s40364-018-0129-8. eCollections 2018 PMID: 29713473
Dr. Ades' research focuses on how to best identify patients who are at the highest risk of developing deep venous clots or pulmonary embolism in the setting of cancer and how to prevent these complications from occurring.
Postdoctoral Training
2002-2005..... Masters Degree in Epidemiology and Biostatistics
2000-2002..... Research Fellow, Tufts University School of Medicine, Boston, MA
1999-2002..... Hematology/Oncology Fellowship, Tufts University, Boston MA
1996-1999..... Queens University postgraduate education in Internal Medicine (Kingston General & Hotel Dieu Hospitals, Kingston, Ontario)
Education
1992-1996..... McGill University, Montreal, Canada; MDCM
1989-1992..... McGill University, Montreal Canada; BS
Publications
To view more and/or the most recent publications by Steven Ades please visit their biblography here.
Ng HK, Rogala BG, Ades S, Schwartz JR, Ashikaga T, Vacek P, Holmes CE. Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation. J Oncol Pharm Pract. 2020 Feb 11: 1078155220901569. doi: 10.1177/1078155220901569. PMID: 32046579
Douce DR, Holmes CE, Cushman M, MacLean C, Ades S, Zakai NA. Risk Factors for Cancer-Associated Venous Thromboembolism: the Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PAAC) Study. J Thromb Haemost. 2019 Aug 18. doi: 10.1111/jth.14614. PMID: 31423717
Yang MX, Coates RF, Ambaye A, Cortright V, Mitchell JM, Buskey AM, Zubarik R, Liu JG, Ades S, Barry MM. NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors. Biomark Res. 2018 Apr 18,6:15. doi: 10.1186/s40364-018-0129-8. eCollections 2018 PMID: 29713473